You're browsing as a guest. Sign in to unlock all features.
IRWD
Ironwood Pharmaceuticals·Drug Manufacturers - Specialty & Generic·United States
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationa...
1 Total1 External0 In-site
IRWDIronwood Pharmaceuticals
2026-01-22🏥 HealthcareAnalysis
Externalby The Abominable sNOw Man · Substack
IRWD: The Earnings Call You Can't Afford to Miss! Just My TWO CENTS
Ironwood Pharma (IRWD) is poised for strong earnings due to its Linzess royalty stream with Abbvie, a large cash position, and an upcoming update on its pipeline drug Apraglutide. The author expects a significant earnings beat and a subsequent stock re-rating, arguing that current consensus estimates are far too low. Key catalysts include an update on the strategic review process, the Apraglutide trial results, and expected analyst upgrades. The author also notes significant open interest in call options, suggesting bullish sentiment.